Details for 2018709129
Up to date per 02.04.2026
Actions
Details for 2018709129
Granted/Registered
European Patent
13.11.2019 A
02.03.2022 B1
06.01.2017
US
201762443244 P
03.11.2017
US
201762581355 P
13.11.2017
US
201762585326 P
C07D 233/91 20060101AFI20180713BHEP
Owner
Rivus Pharmaceuticals, Inc.706B Forest Street Charlottesville, VA 22903US
Representative
No representatives present
Inventor
KHAN, Shaharyar M.1107 Pike Place Charlottesville, VA 22901US
Information about Fees